Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |